PhytoSquene® is a plant-based squalene developed by Evonik for use in pharmaceutical applications such as vaccine adjuvants. As the world’s first plant-based squalene available in GMP quality, PhytoSquene® offers pharmaceutical companies the opportunity to improve the safety and sustainability of their products.
In this webinar, our experts present data from a study that compares the physical chemical attributes and in vitro toxicity effects of GMP-grade PhytoSquene® with animal-derived squalene.
In this webinar you will learn about:
- Squalene and its applications in vaccine adjuvants
- The challenges with using shark-derived squalene
- Comparability studies showing that PhytoSquene® matches the performance of animal-derived squalene